Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has…
New Delhi, February 08, 2018: YL Biologics declared that a worldwide stage III clinical trial of its investigational Etanercept biosimilar (YLB113) has…